These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions. LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779 [TBL] [Abstract][Full Text] [Related]
24. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B. Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344 [TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of phosphoinositides in human platelets. Suga K; Kambayashi J; Kawasaki T; Sakon M; Mori T Thromb Res; 1986 Oct; 44(2):155-63. PubMed ID: 3024354 [TBL] [Abstract][Full Text] [Related]
26. Cyclic nucleotide-binding proteins detected by photoaffinity labeling in nucleus and cytoplasm of bovine liver. Friedman DL; Chambers DA Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5286-90. PubMed ID: 214781 [TBL] [Abstract][Full Text] [Related]
27. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3). He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240 [TBL] [Abstract][Full Text] [Related]
28. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3. Beierwaltes WH Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359 [TBL] [Abstract][Full Text] [Related]
29. Evidence for the presence of essential histidine and cysteine residues in platelet cGMP-inhibited phosphodiesterase. Ghazaleh FA; Omburo GA; Colman RW Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):495-501. PubMed ID: 8713077 [TBL] [Abstract][Full Text] [Related]
30. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473 [TBL] [Abstract][Full Text] [Related]
31. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension. Murray F; MacLean MR; Pyne NJ Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227 [TBL] [Abstract][Full Text] [Related]
32. Guanosine 3',5'-cyclic nucleotide binding proteins of bovine retina identified by photoaffinity labeling. Thompson DA; Khorana HG Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2201-5. PubMed ID: 2156264 [TBL] [Abstract][Full Text] [Related]
33. Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes. el-Daher SS; Eigenthaler M; Walter U; Furuichi T; Miyawaki A; Mikoshiba K; Kakkar VV; Authi KS Thromb Haemost; 1996 Dec; 76(6):1063-71. PubMed ID: 8972032 [TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of endogenous protein in primate kidney. Effects of cyclic AMP. Laminski NA; Hammond KD; Meyers AM Comp Biochem Physiol B; 1992 Sep; 103(1):267-73. PubMed ID: 1333386 [TBL] [Abstract][Full Text] [Related]
35. Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors. Butley MS; Stoner GD; Beer DG; Beer DS; Mason RJ; Malkinson AM Cancer Res; 1985 Aug; 45(8):3677-85. PubMed ID: 2990675 [TBL] [Abstract][Full Text] [Related]
36. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. Halbrügge M; Friedrich C; Eigenthaler M; Schanzenbächer P; Walter U J Biol Chem; 1990 Feb; 265(6):3088-93. PubMed ID: 2154470 [TBL] [Abstract][Full Text] [Related]
37. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases. Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933 [TBL] [Abstract][Full Text] [Related]
38. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810 [TBL] [Abstract][Full Text] [Related]
40. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5. Dunkern TR; Hatzelmann A Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]